NeuroproteXeon
Manufacturing · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
50 Cobham Dr, Orchard Park, New York, 14...Phone Number
(716) 332-7200Website
www.neuroprotexeon.comRevenue
<$5 MillionIndustry
About NeuroproteXeon
NeuroproteXeon, Inc. is a clinical-stage pharmaceutical/device company developing xenon to improve functional capabilities and survival in patients with Post-Cardiac Arrest Syndrome ("PCAS"). The Company has a license agreement with Mallinckrodt LLC (NYSE:MNK) for the sale and distribution of xenon gas for inhalation in North America, Australia and Japan upon approval of the drug in those markets.Explore more
NeuroproteXeon Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to NeuroproteXeon
Compare insights from companies similar to NeuroproteXeon, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
NeuroproteXeon Tech Stack
A closer look at the technologies used by NeuroproteXeon
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NeuroproteXeon
Sign Up For FreeTo access detailed company insights
NeuroproteXeon, Inc. is a clinical-stage pharmaceutical/device company developing xenon to improve functional capabilities and survival in patients with Post-Cardiac Arrest Syndrome ("PCAS"). The Company has a license agreement with Mallinckrodt LLC (NYSE:MNK) for the sale and distribution of xenon gas for inhalation in North America, Australia and... Read More
